PK/PD analysis of methotrexate in the rheumatic treatment made use of genetic polymorphism of drug delivery protein and clinical development
Not Applicable
- Conditions
- Rheumatic arthritis
- Registration Number
- JPRN-UMIN000001609
- Lead Sponsor
- Oita University Hospital Clinical pharmacology center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of severe circulatory disease, hepatic disorder,renal disease, digestive system disease, blood disorder, interstitial pneumonia. 2.The patient which treatment of RA is no good. 3.The patient having therapeutic experience of surgical remedy for RA during study participation. 4.A pregnant woman, nursing mother, a person who hope for the pregnancy all over the study period.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method